SCHEMBL5228909

SCHEMBL5228909

CCN(c1ccc(F)cc1)C(C)C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
THRB P10828 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
HPGD P15428 2/20 0.36
FPR2 P25090 1/20 0.36
SCN9A Q15858 1/20 0.36
KMT2A Q03164 2/20 0.36
TAAR1 Q96RJ0 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
S1PR1 P21453 1/20 0.36
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35
MAOA P21397 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12656175 0.83 CYP3A4 (0.42) ALDH1A1MAPTKDM4EHTTKMT2A
Hydrochloric Acid SCHEMBL11323929 0.83 ALDH1A1 (0.44) ALDH1A1MAPTKDM4EGAAMAPK1
SCHEMBL4667661 0.83 ALDH1A1 (0.47) ALDH1A1MAPTKMT2AMEN1TSHR
SCHEMBL22828119 0.81 S1PR1 (0.40) FPR2SCN9AS1PR1
SCHEMBL3825190 0.76 CACNA1H (0.44) TAAR1S1PR1
SCHEMBL2186158 0.76 MAOB (0.61) SCN9AMAOAMAOB
SCHEMBL13181093 0.76 TAAR1 (0.50) ALDH1A1MAPTKDM4EGAATHRB
SCHEMBL2185724 0.75 SCN9A (0.57) SCN9AMAOB
SCHEMBL22688174 0.73 ESRRG (0.43) ALDH1A1MAPTKDM4EGAATHRB
SCHEMBL12247771 0.72 PARP1 (0.44) ALDH1A1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817275-A1 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS Schering Aktiengesellschaft (DE) 2007-08-15 EP disclosed
EP-1799645-A2 PROCESSES AND INTERMEDIATES FOR PREPARING CYSTEINE PROTEASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2007-06-27 EP disclosed
WO-2006060494-A1 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2006-06-08 WO disclosed
WO-2006034004-A2 PROCESSES AND INTERMEDIATES FOR PREPARING CYSTEINE PROTEASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 2006-03-30 WO disclosed